FDA Import Refusal 799-7786712-6/11/1 — Sanofi Canada
The FDA refused shipment 799-7786712-6/11/1 from Sanofi Canada (Canada) on Nov 7, 2023. The refused product falls under Drugs and Biologics — INSULIN (INJ) (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Nov 7, 2023
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY17 INSULIN (INJ) (ANTI-DIABETIC)
- Charges
- 75